These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8305515)

  • 1. Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.
    Akerblom E; Dohlsten M; Brynö C; Mastej M; Steringer I; Hedlund G; Lando P; Kalland T
    Bioconjug Chem; 1993; 4(6):455-66. PubMed ID: 8305515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells.
    Dohlsten M; Sundstedt A; Björklund M; Hedlund G; Kalland T
    Int J Cancer; 1993 May; 54(3):482-8. PubMed ID: 8509223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.
    Lando PA; Dohlsten M; Hedlund G; Akerblom E; Kalland T
    Cancer Immunol Immunother; 1993; 36(4):223-8. PubMed ID: 8439985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
    Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
    Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
    Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
    Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
    Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of superantigens.
    Kalland T; Dohlsten M; Abrahmsén L; Hedlund G; Björk P; Lando PA; Sundstedt A; Akerblom E; Lind P
    Cell Biophys; 1993; 22(1-3):147-64. PubMed ID: 7889537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
    Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
    Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
    Sinkule JA; Rosen ST; Radosevich JA
    Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
    Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
    Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
    Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
    J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
    Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
    Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
    Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
    J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
    Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
    Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
    Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
    J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
    Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
    Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.